Status:

WITHDRAWN

Comparison of Proton and Carbon Ion Radiotherapy With Advanced Photon Radiotherapy in Skull Base Meningiomas: The PINOCCHIO Trial.

Lead Sponsor:

University Hospital Heidelberg

Conditions:

Skull Base Meningioma

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

In PINOCCHIO-Triayl, carbon ion radiotherapy is compared to proton and advanced photon radiotherapy in patients with skull base meningiomas. There will be two treatment arms with photons, one arm with...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Patients meeting all of the following criteria will be considered for admission to the trial:
  • Histologically or imaging confirmed skull base meningioma
  • macroscopic tumor - Simpson Grade 4 or 5
  • age ≥ 18 years of age
  • Karnofsky Performance Score \>=60
  • For women with childbearing potential, (and men) adequate contraception (sexual abstinence, estrogen- or gestagen containing contraceptive medication etc.)
  • Female participants: No pregnancy present (pregnancy test required)
  • Ability of subject to understand character and individual consequences of the clinical trial
  • Written informed consent (must be available before enrolment in the trial)
  • Exclusion criteria:
  • Patients presenting with any of the following criteria will not be included in the trial:
  • refusal of the patients to take part in the study
  • previous radiotherapy of the brain
  • histologically confirmed atypical or anaplastic meningioma
  • optic nerve sheath meningioma (ONSM)
  • Patients who have not yet recovered from acute toxicities of prior therapies
  • Known carcinoma \< 5 years ago (excluding Carcinoma in situ of the cervix, basal cell carcinoma, squamous cell carcinoma of the skin) requiring immediate treatment interfering with study therapy
  • Pregnant or lactating women
  • Participation in another clinical study or observation period of competing trials, respectively.

Exclusion

    Key Trial Info

    Start Date :

    May 1 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    May 1 2022

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT01795300

    Start Date

    May 1 2020

    End Date

    May 1 2022

    Last Update

    October 6 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University Hospital of Heidelberg, Radiation Oncology

    Heidelberg, Germany, 69120